Quorum Health Corp (NYSE:QHC)’s share price rose 5% on Wednesday . The stock traded as high as $6.61 and last traded at $6.47, with a volume of 283,508 shares changing hands. The stock had previously closed at $6.16.
QHC has been the topic of several research reports. Mizuho reiterated a “neutral” rating on shares of Quorum Health Corp in a report on Tuesday, August 23rd. Morgan Stanley restated a “hold” rating on shares of Quorum Health Corp in a report on Thursday, August 11th. Credit Suisse Group AG restated a “hold” rating and issued a $6.00 target price on shares of Quorum Health Corp in a report on Wednesday, August 31st. Royal Bank Of Canada initiated coverage on shares of Quorum Health Corp in a report on Thursday, June 2nd. They issued a “sector perform” rating and a $13.00 target price on the stock. Finally, Susquehanna initiated coverage on shares of Quorum Health Corp in a report on Wednesday, June 8th. They issued a “neutral” rating and a $11.00 target price on the stock. Seven equities research analysts have rated the stock with a hold rating, The stock currently has an average rating of “Hold” and an average target price of $9.68.
The stock has a 50 day moving average price of $8.25 and a 200 day moving average price of $10.19. The stock’s market capitalization is $201.25 million.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/07/quorum-health-corp-qhc-stock-price-up-5.html
Quorum Health Corp (NYSE:QHC) last announced its quarterly earnings results on Wednesday, August 10th. The company reported ($8.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.11 by $8.74. The business had revenue of $529.70 million for the quarter, compared to analyst estimates of $564.19 million. The business’s revenue for the quarter was down 1.6% on a year-over-year basis. On average, analysts predict that Quorum Health Corp will post ($1.95) earnings per share for the current fiscal year.
In other news, insider Thomas Daniel Miller purchased 48,200 shares of the business’s stock in a transaction on Monday, August 15th. The shares were acquired at an average price of $5.85 per share, with a total value of $281,970.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Michael J. Culotta purchased 80,000 shares of the business’s stock in a transaction on Monday, August 15th. The stock was purchased at an average cost of $5.98 per share, for a total transaction of $478,400.00. Following the acquisition, the chief financial officer now owns 164,747 shares in the company, valued at $985,187.06. The disclosure for this purchase can be found here.
Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).
Receive News & Ratings for Quorum Health Corp Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Quorum Health Corp and related companies with MarketBeat.com’s FREE daily email newsletter.